Javascript must be enabled to continue!
Coughing up a Cure for Whooping Cough with Pertussis Toxin
View through CrossRef
The CDC reported 32,971 cases of pertussis, or whooping cough, in 2014. This respiratory infection mainly affects unvaccinated infants and toddlers, and symptoms include paroxysmal coughing with whooping, vomiting, and pulmonary complications which can lead to death. Pertussis toxin (PT), produced by the pathogenic bacteria
Bordetella pertussis
, causes whooping cough by ADP‐ribosylating the G
i
protein that inactivates adenylyl cyclase. The inactive ADP‐ribosylated G
i
protein is unable to interact with G protein‐coupled receptors, leading to an increased intracellular concentration of cAMP. Increased concentrations of cAMP can interfere with normal cell signaling, disrupting specific cellular functions. PT is a critical virulence factor for
B. pertussis
that also has potential to create human immunity against pertussis. The Cedarburg SMART Team (Students Modeling A Research Topic) modeled PT using 3‐D printing technology to study structure‐function relationships. PT contains a total of six subunits, four individual subunits (S1, S2, S3, and S5) and a pair of identical subunits (S4). The A domain consists of the S1 subunit, the catalytic portion of the toxin. Mutations in Glu129 and His35 can reduce ADP‐ribosyltransferase activity. Mutations in Arg9, Asp11, and Arg13 also reduce catalytic activity. Trp26 interacts with NAD
+
, an important cofactor. The B domain, responsible for binding to cell receptors, contains the remaining subunits. Effective vaccines contain chemically‐inactivated PT. However, whole cell pertussis vaccine may cause severe side effects, while acellular pertussis vaccine is not as potent. Non‐toxic derivatives of pertussis toxin may be engineered, improving the potency of the acellular vaccine without harmful side effects.
Support or Funding Information
This work was supported by the National Institutes of of Health Science Education Partnership Award (NIH‐SEPA 1R25OD010505‐01) and the National Institutes of Health Clinical and Translational Science Award (NIH‐CTSA UL1RR031973).
Title: Coughing up a Cure for Whooping Cough with Pertussis Toxin
Description:
The CDC reported 32,971 cases of pertussis, or whooping cough, in 2014.
This respiratory infection mainly affects unvaccinated infants and toddlers, and symptoms include paroxysmal coughing with whooping, vomiting, and pulmonary complications which can lead to death.
Pertussis toxin (PT), produced by the pathogenic bacteria
Bordetella pertussis
, causes whooping cough by ADP‐ribosylating the G
i
protein that inactivates adenylyl cyclase.
The inactive ADP‐ribosylated G
i
protein is unable to interact with G protein‐coupled receptors, leading to an increased intracellular concentration of cAMP.
Increased concentrations of cAMP can interfere with normal cell signaling, disrupting specific cellular functions.
PT is a critical virulence factor for
B.
pertussis
that also has potential to create human immunity against pertussis.
The Cedarburg SMART Team (Students Modeling A Research Topic) modeled PT using 3‐D printing technology to study structure‐function relationships.
PT contains a total of six subunits, four individual subunits (S1, S2, S3, and S5) and a pair of identical subunits (S4).
The A domain consists of the S1 subunit, the catalytic portion of the toxin.
Mutations in Glu129 and His35 can reduce ADP‐ribosyltransferase activity.
Mutations in Arg9, Asp11, and Arg13 also reduce catalytic activity.
Trp26 interacts with NAD
+
, an important cofactor.
The B domain, responsible for binding to cell receptors, contains the remaining subunits.
Effective vaccines contain chemically‐inactivated PT.
However, whole cell pertussis vaccine may cause severe side effects, while acellular pertussis vaccine is not as potent.
Non‐toxic derivatives of pertussis toxin may be engineered, improving the potency of the acellular vaccine without harmful side effects.
Support or Funding Information
This work was supported by the National Institutes of of Health Science Education Partnership Award (NIH‐SEPA 1R25OD010505‐01) and the National Institutes of Health Clinical and Translational Science Award (NIH‐CTSA UL1RR031973).
Related Results
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco
Abstract
Background
In recent decades, there has been a marked increase in the number of reported cases of pertussis around the world, and pertussis continues to be a frequently oc...
Pertussis in Poland in 2022
Pertussis in Poland in 2022
IntroductionThe epidemiological situation of pertussis in Poland in 2022 was influenced by the cancellation of the COVID-19 epidemic and the introduction of an epidemic threat. Dec...
Lymphocyte receptors for pertussis toxin
Lymphocyte receptors for pertussis toxin
We have investigated human T-lymphocyte receptors for pertussis toxin by affinity isolation and photoaffinity labeling procedures. T lymphocytes were obtained from peripheral human...
CLINICAL SYMPTOMS AND COMPLICATIONS OF WHOOPING COUGH IN CHILDREN AND ADULTS
CLINICAL SYMPTOMS AND COMPLICATIONS OF WHOOPING COUGH IN CHILDREN AND ADULTS
Clinical symptoms of whooping cough were observed in 100 children and 16 adults who fell ill in 1976–1977 during two whooping cough epidemics and as sporadic cases. The diagnosis o...
Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model
Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model
Since the 2000s, sporadic outbreaks of whooping cough have been reported in advanced countries, where the acellular pertussis vaccination rate is relatively high, and in developing...
Association of Pertussis Toxin with Severe Pertussis Disease
Association of Pertussis Toxin with Severe Pertussis Disease
Pertussis, caused by respiratory tract infection with the bacterial pathogen Bordetella pertussis, has long been considered to be a toxin-mediated disease. Bacteria adhere and mult...
Lipooligosaccharide, Vag8, and pertussis toxin of
Bordetella pertussis
cooperatively cause coughing in mice
Lipooligosaccharide, Vag8, and pertussis toxin of
Bordetella pertussis
cooperatively cause coughing in mice
Summary
Whooping cough, a contagious respiratory disease caused by
Bordetella pertussis
, is characterized by...

